Risk factor analysis for survival and graft versus host disease in patients with chronic myelogenous leukemia submitted to allogeneic bone marrow transplantation.

被引：0
|
作者：
Moreira, VA [1 ]
Oliveira, FAM [1 ]
Pasquini, R [1 ]
de Medeiros, CR [1 ]
机构：
[1] Univ Fed Parana, Bone Marrow Transplantat Serv, BR-80060000 Curitiba, Parana, Brazil
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4950
引用
收藏
页码：385B / 385B
页数：1
相关论文
共 50 条
  • [21] Impaired thymic negative selection causes chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sakoda, Y
    Hashimoto, D
    Takeuchi, K
    Asakura, S
    Akashi, K
    Tanimoto, M
    Harada, M
    Teshima, T
    BLOOD, 2005, 106 (11) : 137A - 137A
  • [22] THE GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
    MARMONT, AM
    LEUKEMIA & LYMPHOMA, 1993, 11 : 221 - 226
  • [23] Bi-directional tolerance following cadaveric liver transplantation for chronic graft versus host disease after allogeneic bone marrow transplantation.
    Urban, CE
    Schwinger, W
    Deutschmann, A
    Lackner, H
    Koenigsrainer, A
    Margreiter, R
    BLOOD, 2002, 100 (11) : 447B - 448B
  • [24] ALLOGENEIC SKIN TRANSPLANTATION IN CHRONIC GRAFT-VERSUS-HOST DISEASE FOLLOWING BONE-MARROW TRANSPLANTATION
    BAUMEISTER, RGH
    RIEL, KA
    KOLB, HJ
    CHIRURG, 1990, 61 (06): : 438 - 440
  • [25] Targeted Agents for Chronic Myelogenous Leukemia: Will That Be the End of Allogeneic Bone Marrow Transplantation for That Disease?
    Liang, Yuzhen
    Lai, Yongrong
    Schwarzenberger, Paul
    Li, Qiaochuan
    Ma, Jie
    Luo, Jun
    Liu, Rongrong
    Shi, Lingling
    Zhou, Jicheng
    Peng, Zhigang
    Yang, Jie
    Deng, Donghong
    Zhou, Yizhen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (06) : 848 - 853
  • [26] A RETROSPECTIVE ANALYSIS OF THE LONG-TERM EFFECT OF SPLENECTOMY ON LATE INFECTIONS, GRAFT-VERSUS-HOST DISEASE, RELAPSE, AND SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    KALHS, P
    SCHWARZINGER, I
    ANDERSON, G
    MORI, M
    CLIFT, RA
    STORB, R
    BUCKNER, CD
    APPELBAUM, FR
    HANSEN, JA
    SULLIVAN, KM
    BLOOD, 1995, 86 (05) : 2028 - 2032
  • [27] Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation
    Kami, M
    Kanda, Y
    Sasaki, M
    Takeda, N
    Tanaka, Y
    Saito, T
    Ogawa, S
    Honda, H
    Chiba, S
    Mitani, K
    Hirai, H
    Yazaki, Y
    BONE MARROW TRANSPLANTATION, 1998, 21 (07) : 721 - 723
  • [28] Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation
    Okada, M
    Okamoto, T
    Yamada, S
    Yamada, S
    Itoh, T
    Mori, A
    Saheki, K
    Takatsuka, H
    Wada, H
    Tamura, A
    Fujimori, Y
    Takemoto, Y
    Kakishita, E
    ACTA HAEMATOLOGICA, 1999, 102 (02) : 107 - 109
  • [29] Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation
    Nagashima, T
    Sato, F
    Chuma, T
    Mano, Y
    Sasaki, I
    Mori, M
    Higa, T
    Masauji, N
    Kasai, M
    Orba, Y
    Shinohara, T
    Nagashima, K
    NEUROPATHOLOGY, 2002, 22 (01) : 1 - 8
  • [30] Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation
    Nakamura, S
    Hiroki, A
    Shinohara, M
    Gondo, H
    Ohyama, Y
    Mouri, T
    Sasaki, M
    Shirasuna, K
    Harada, M
    Niho, Y
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1996, 82 (05): : 556 - 563
12345